Growth is "exhausted" at Johnson Matthey, says Exane BNP Paribas
Exane BNP Paribas sees lower medium-term structural growth and growing risks at Johnson Matthey, as it lowered its stance on the chemicals outfit from 'outperform' to 'neutral'. The broker, which cut its target price by 7% to 3,300p, said that growth was "exhausted" at the company, which specialises
Read more